Last edited:
AAPL is up to $216. How much growth is left
100% agree. For me it makes little sense to sell a stock where I am sitting on a 761% gain, when I have many other stocks that are just as vulnerable to corrections that have lower gains.I am 100% letting the tax tail wag my APPL dog. I'd love to trim the position, but I've held for so long I don't wanna pay a massive tax bill this year.
AAPL is an interesting stock. Obviously Mag 7, yet kind of defensive due to remarkable cash flow, buybacks, and loyal customer base. Probably one of the last stocks that should be sold.100% agree. For me it makes little sense to sell a stock where I am sitting on a 761% gain, when I have many other stocks that are just as vulnerable to corrections that have lower gains.
I've read about Structure Therapeutics a few weeks ago. It's one of the small companies trying to break into the GLP-1 race (with oral being the holy grail). Viking Therapeutics is also another name that comes up quite often. It's a crowded space and I assume if one of these assets hit in clinical trial, the company would get bought by Novo or Lilly.@T2Kplus20 , what do you know/think about GPCR? I just got a strong buy recommendation for this small cap bio company.
Sounds like OCGN may need to do a big raise very soon. May be a good buying opportunity afterwards!Sorry to hear you lost money on this. At the time I mentioned Ocugen on this board, just a few months ago, it was selling at $0.56 per share. As I write this, it is at $1.76 per share.
I’m definitely staying in. I bought my first 300 shares 3 years ago at $10 per share, and kept buying more as the price kept dropping, all the way down to $0.35 per share, because I believe in the company and the products they’re developing.
Today I have 15,000 shares at 1.69 average. I won’t sell any until it hits almost $5 per share, which I believe will happen this year. Even then I will keep 80% of my holdings longer term.
The catalysts going forward, now that they’ve achieved NASDAQ compliance, include a forthcoming partnership with a big pharma company (rumored to be JnJ but that’s just random speculation because both companies are developing ocular degeneration treatments).
They are starting phase 3 trials next month for one of their ocular treatments and they have started building a factory to manufacture their knee cartilage product.
They also have a nasal delivery vaccine in development.
Please note that I am only sharing what I know and why I’ve been accumulating shares of this stock. None of what I’m saying is intended to be advice or even a recommendation.
Hope this helps, good luck.
Possibly. If they announce a partnership first, it will give cover to any dilution that may follow.Sounds like OCGN may need to do a big raise very soon. May be a good buying opportunity afterwards!
Touched $230 this morning. Good buy. I’d expect a lot of momentum into the robo-taxi event in August.TSLA up over $200
What do you expect to hear on Robotaxi-taxi?Touched $230 this morning. Good buy. I’d expect a lot of momentum into the robo-taxi event in August.
Happy I bought the dip and added to my position.Touched $230 this morning. Good buy. I’d expect a lot of momentum into the robo-taxi event in August.
Not exactly sure, that’s why I said the momentum would run into the event. Could very well be a sell the news situation short-term. A demo of the actual vehicle would be nice. If there’s a clear timeline and any connection to a cheaper model, I’d expect this run to continue.What do you expect to hear on Robotaxi-taxi?
Depending on the run up I may sell prior.Touched $230 this morning. Good buy. I’d expect a lot of momentum into the robo-taxi event in August.
Closed over $230 and blasted through the 200-day MA.Depending on the run up I may sell prior.
If it’s not too off the rails it could be very similar to the reaction of apples ai announcement
Ya truthfully it's already way ahead of that Apple move. Probably not that comparable.Closed over $230 and blasted through the 200-day MA.
Decreased production was expected due to the plant closure. Need to find a good re-entry point. Also eyeing UBER, may with leap calls. You still in on that one?RIVN with a nice day as well. Up nearly 7%.
"Rivian reported second-quarter deliveries of 13,790 vehicles, up about 9% year over year. Wall Street was looking for about 12,000 units. Production dipped though. Rivian made about 9,600 vehicles, down from almost 14,000 produced in the first quarter of 2024."
Ya, one of my biggest positions.Decreased production was expected due to the plant closure. Need to find a good re-entry point. Also eyeing UBER, may with leap calls. You still in on that one?
The market is about expectations, not absolute values.
Can’t imagine the delivery story is driving this rally. Guessing investors are hoping Musk can pull a rabbit out of his hat during the investor’s day.
Seeing a lot of notes like this out there as well…
Can’t imagine the delivery story is driving this rally. Guessing investors are hoping Musk can pull a rabbit out of his hat during the investor’s day.
TSLA continues to pump. Over $245 to close this short session.Seeing a lot of notes like this out there as well…
Fade the greatest stock picker of our time at your own risk.TSLA continues to pump. Over $245 to close this short session.
Although I was already proportionally heavy in energy, I took a position in SLB two weeks ago. So far so good; up over 6%. I’m sticking with all my energy related stocks, and also picked up D, SO and NEE recently.SLB, down to near 20 year P/E lows at around 15x.
This despite rev and EPS having grown consistently off the Covid lows. And those rev's and EPS are expected to continue to grow.
So EPS growth as well as multiple expansion possible here.
A big Stephanie Link pick, calls it a stealth technology play, and recently added to her position(I'm thinking of doing the same), though she admits it has dissapointed for nearly a year now.
Current div of 2.36%.
I haven’t tracked this specifically, but I believe I am in the green by a fair amount. Most of my option plays turn out to be losers, but the few I really hit on, the returns were crazy. So low batting average but high HR rate. LOL!I have a question for all you options traders since the vast majority of options traders lose money (including me, tried it years ago unsuccessfully). How many of you are in the green vs the red and what are the ROI for those that are profitable?
I’ve typically sold calls or sometimes puts. Haven’t really bought muchI have a question for all you options traders since the vast majority of options traders lose money (including me, tried it years ago unsuccessfully). How many of you are in the green vs the red and what are the ROI for those that are profitable?
I have a small position with D. All three of those you mentioned are utilities, right? Other than SLB, which others are you bullish on? SLB seems like a good play.Although I was already proportionally heavy in energy, I took a position in SLB two weeks ago. So far so good; up over 6%. I’m sticking with all my energy related stocks, and also picked up D, SO and NEE recently.
TSLA + China:Fade the greatest stock picker of our time at your own risk.
I have OXY, CVX, XOM, ENB, DVN, KMI, and SWN. Wouldn’t say bullish, but energy usage will continue to rise for the foreseeable future and I also get the dividend.I have a small position with D. All three of those you mentioned are utilities, right? Other than SLB, which others are you bullish on? SLB seems like a good play.
About 50 million Americans own BTC, including a majority of those from younger generations. As the boomers and Schiff's of the world die off, demand for BTC will continue to grow. Simple supply and demand.Bitcoin is not stonk. Peter Schiff is nothing but a gold salesman huckster scoundrel (but who likes to clip bond coupons anyway😂?) but I think he’s right about Bitcoin.
HODLing is for stonks and bonds only.